Type of Study:
Type 1 diabetes patients who are over 18 years of age
Study Length:
31 Weeks
Target Age/Sex:
over 18 years, Male and Female
Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures
Staus: Closed
Description:
The BDCP clinical study is for type 1 diabetes patients, 18 years or older, to evaluate the safety of LY3209590 in patients being treated with multiple daily injection therapy.
